Tus kws kho mob
P74-22 Update to Claims Timely Filing Limits and Appeal Submission Timeframes
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1821 - 1830 ntawm 4139
Tus kws kho mob
P76-22 No-Load Miles (Deadhead) Reimbursement Rate for Minnesota Health Care Programs Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P77-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P75-22 Update to 2023 Renewal Changes Summaries for BP PCC & Institutional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2022
Tus kws kho mob
upcoming-policies-effective-january-30-2023.pdf
Tus kws kho mob
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 23, 2022
Tus kws kho mob
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 23, 2022
Tus kws kho mob
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 23, 2022
Tus kws kho mob
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 23, 2022